Orthocell Says June Quarter Revenue Rises 36% Year-over-Year to New Record

MT Newswires Live
07/13

Orthocell (ASX:OCC) said its revenue came in at AU$3.8 million for the June quarter, up 36% year-over-year from AU$2.8 million in the prior-year quarter, according to a Monday Australian bourse filing.

Cash receipts from customers totalled AU$2.5 million for the quarter, compared to AU$1.6 million in the prior quarter

Its revenue for fiscal year 2026 came in at AU$13.2 million, up 44%.

The firm attributed the rise in revenue to continued adoption of Remplir in Australia and accelerating commercial adoption in the US. Total international revenue from Remplir sales comprises 9% of total quarterly revenue.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10